Tamoxifen, raloxifene findings unlikely to encourage genetic screening for breast cancer.
Dove
A
A
D024682:BRCA2 Protein; D001943:Breast Neoplasms / Q000235:genetics / Q000517:prevention & control*; D004965:Estrogen Antagonists / Q000627:therapeutic use*; D004967:Estrogens / Q000819:agonists; D005260:Female; D019398:Genes, BRCA1 / Q000235:genetics; D005820:Genetic Testing; D006801:Humans; D009363:Neoplasm Proteins / Q000235:genetics; D010880:Piperidines / Q000627:therapeutic use*; D020849:Raloxifene Hydrochloride; D013629:Tamoxifen / Q000627:therapeutic use*; D014157:Transcription Factors / Q000235:genetics
D024682:BRCA2 Protein; D004965:Estrogen Antagonists; D004967:Estrogens; D009363:Neoplasm Proteins; D010880:Piperidines; D014157:Transcription Factors; D013629:Tamoxifen; D020849:Raloxifene Hydrochloride